Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/89185
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action |
Autor: | Mocci, Giuseppe CSIC; Jiménez-Sánchez, Laura CSIC; Adell, Albert CSIC ORCID ; Cortés, Roser CSIC ORCID; Artigas, Francesc CSIC ORCID | Palabras clave: | Atypical antipsychotics Dopamine Mesolimbic pathway Pyramidal neurons Schizophrenia Serotonin receptors |
Fecha de publicación: | nov-2013 | Editor: | Elsevier | Citación: | Neuropharmacology 79: 49-58 (2013) | Resumen: | The prefrontal cortex (PFC) is involved in higher brain functions altered in schizophrenia. Classical antipsychotic drugs modulate information processing in cortico-limbic circuits via dopamine D2 receptor blockade in nucleus accumbens (NAc) whereas atypical antipsychotic drugs preferentially target cortical serotonin (5-HT) receptors. The brain networks involved in the therapeutic action of atypical drugs are not fully understood. Previous work indicated that medial PFC (mPFC) pyramidal neurons projecting to ventral tegmental area express 5-HT2A receptors suggesting that atypical antipsychotic drugs modulate dopaminergic activity distally, via 5-HT2A receptor (5-HT2A-R) blockade in PFC. Since the mPFC also projects heavily to NAc, we examined whether NAc-projecting pyramidal neurons also express 5-HT2A-R. Using a combination of retrograde tracing experiments and in situ hybridization we report that a substantial proportion of mPFC-NAc pyramidal neurons in rat brain express 5-HT2A-R mRNA in a layer- and area-specific manner (up to 68% in layer V of contralateral cingulate). The functional relevance of 5-HT2A-R to modulate mPFC-NAc projections was examined in dual-probe microdialysis experiments. The application of the preferential 5-HT2A-R agonist DOI into mPFC enhanced glutamate release locally (+66 ± 18%) and in NAc (+74 ± 12%) indicating that cortical 5-HT2A-R activation augments glutamatergic transmission in NAc. Since NAc integrates glutamatergic and dopaminergic inputs, blockade of 5-HT2A-R by atypical drugs may reduce cortical excitatory inputs onto GABAergic neurons of NAc, adding to dopamine D2 receptor blockade. Together with previous observations, the present results suggest that atypical antipsychotic drugs may control the activity of the mesolimbic pathway at cell body and terminal level. | Versión del editor: | http://dx.doi.org/10.1016/j.neuropharm.2013.10.021 | URI: | http://hdl.handle.net/10261/89185 | DOI: | 10.1016/j.neuropharm.2013.10.021 | ISSN: | 0028-3908 | E-ISSN: | 1873-7064 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Expression of 5-HT2A.pdf | 653,4 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
43
checked on 24-abr-2024
WEB OF SCIENCETM
Citations
41
checked on 26-feb-2024
Page view(s)
403
checked on 25-abr-2024
Download(s)
788
checked on 25-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.